Nektar Therapeutics
NKTR
NKTR
124 hedge funds and large institutions have $67.6M invested in Nektar Therapeutics in 2023 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 30 increasing their positions, 46 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
35% less repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 46
44% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 25
Holders
124
Holding in Top 10
–
Calls
$6K
Puts
$3K
Top Buyers
| 1 | +$1.93M | |
| 2 | +$1.24M | |
| 3 | +$1.03M | |
| 4 |
MAM
Monaco Asset Management
Monaco
|
+$658K |
| 5 |
Millennium Management
New York
|
+$229K |
Top Sellers
| 1 | -$11.1M | |
| 2 | -$1.26M | |
| 3 | -$1.14M | |
| 4 |
Verition Fund Management
Greenwich,
Connecticut
|
-$1.04M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$906K |